The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...

Several states, including Massachusetts, began stockpiling the drug after a federal court ruling in Texas blocked the FDA’s ...

The product was made by a manufacturer some consumers may recognize, and expiration timelines make it possible it's still ...

On January 15, the FDA issued an order targeting FD&C Red No. 3, a synthetic coloring agent also known as Red Dye No. 3, Red ...

Low-nicotine cigarettes are not a new idea. Several companies, including Philip Morris, experimented with selling the ...

Over 700 signatures on a public letter to U.S. Senate to reject RFK Jr's nomination to the Health and Human Services ...

The FDA wants front-of-package nutrition labels required on packaged foods. The labels would tell consumers if the product ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

The Food and Drug administration approved Cobenfy in September of 2024, and it is the first new type of treatment for the ...